Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Stems Cells Successfully Transplanted onto Human Cornea

By BiotechDaily International staff writers
Posted on 30 Apr 2012
Scientists for the first time successfully cultivated human embryonic stem cells (hESCs) on damaged human corneas. The procedure may in the future lead to removal of the current dependence on donated corneas of which there continues to be a shortage.

Of the approximately 100,000 corneal transplantations carried out worldwide each year, about 500 take place in Sweden, many of which are carried out at the ophthalmology clinic at Sahlgrenska University Hospital (Mölndal, Sweden). The damaged and cloudy cornea that is turning the patient blind is replaced with a healthy, transparent one. In collaboration with scientists at the Sahlgrenska Academy of the University of Gothenburg (Sweden) and others, defective corneas obtained from the clinic were used in a study to investigate whether cells originating from hESCs could be successfully transplanted onto a partially wounded human cornea, and to examine the ability of the transplanted cells to further differentiate into corneal epithelial-like cells. It is the epithelial cells that maintain the transparency of the cornea.

The method involved in vitro transplantation of differentiated hESCs onto a human corneal button (without limbus) from which the epithelial layer was partially removed. The cells were cultured on Bowman's membrane and the culture dynamics were documented in a time-lapse system. The transplanted cells originated from a genetically engineered hESC line that expresses green fluorescent protein, which facilitated their identification. To detect differentiation into corneal epithelial-like cells, the transplanted cells were analyzed periodically for several days by immunohistochemistry using antibodies specific for relevant markers. The transplanted cells established and expanded on Bowman's membrane, forming a 1-4 cell layer surrounded by host corneal epithelial cells, and expression of a corneal marker began to appear 3 days after transplantation.

The success of these experiments represents an important step towards replacing donated corneas with corneas cultivated from stem cells. “Similar experiments have been carried out on animals, but this is the first time that stem cells have been grown on damaged human corneas. It means that we have taken the first step towards being able to use stem cells to treat damaged corneas,” said Charles Hanson, first author of the study and Associate Professor at the Sahlgrenska Academy.

“If we can establish a routine method for this, the availability of material for patients who need a new cornea will be essentially unlimited. Both the surgical procedures and the aftercare will also become much more simple,” added Ulf Stenevi, senior author of the study and Professor at the Sahlgrenska Academy.

The study was published in the journal Acta Ophthalmologica online ahead of print January 26, 2012.

Related Links:
Sahlgrenska Academy, University of Gothenburg
Sahlgrenska University Hospital


comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Diagram illustrates the innovative process that could lead to more effective drugs against influenza infection (Photo courtesy of the Hebrew University of Jerusalem).

Researchers Show How the Influenza Virus Blocks Natural Killer Cell Recognition

A team of molecular virologists has described how the influenza virus evolved a defense mechanism to protect it from attack by the immune system's natural killer (NK) cells. The recognition of pathogen-infected... Read more

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Lab Technologies

view channel

Genome-Wide Mutation-Searching Computational Software Designed for Genomic Medicine

Analysis software cross-references a patient’s symptoms with his genome sequence to help physicians in the diagnosis of disease. This software was created by a team of scientists from A*STAR’s Genome Institute of Singapore (GIS), led by Dr. Pauline Ng. The research findings were published August 3, 2014, in the journal... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.